Validation of a Proliferation-based Expression Signature as Prognostic Marker in Early Stage Lung Adenocarcinoma

PURPOSE: New prognostic markers to guide treatment decisions in early stage non-small cell lung cancer are necessary to improve patient outcomes. In this report, we assess the utility of a pre-defined mRNA expression signature of cell cycle progression genes (CCP score) to define 5-year risk of lung...

Descrición completa

Gardado en:
Detalles Bibliográficos
Main Authors: Wistuba, Ignacio I., Behrens, Carmen, Lombardi, Francesca, Wagner, Susanne, Fujimoto, Junya, Raso, M. Gabriela, Spaggiari, Lorenzo, Galetta, Domenico, Riley, Robyn, Hughes, Elisha, Reid, Julia, Sangale, Zaina, Swisher, Steven G., Kalhor, Neda, Moran, Cesar A., Gutin, Alexander, Lanchbury, Jerry. S., Barberis, Massimo, Kim, Edward S.
Formato: Artigo
Idioma:Inglês
Publicado: 2013
Assuntos:
Article
Acceso en liña:https://ncbi.nlm.nih.gov/pmc/articles/PMC3834029/
https://ncbi.nlm.nih.gov/pubmed/24048333
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1158/1078-0432.CCR-13-0596
Tags: Engadir etiqueta
Sen Etiquetas, Sexa o primeiro en etiquetar este rexistro!

Títulos similares